PRICE T ROWE ASSOCIATES INC /MD/ - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$262,783
+22.4%
10,407,216
+2.3%
0.04%
+30.0%
Q2 2023$214,637
+26.1%
10,172,296
+1.9%
0.03%
+20.0%
Q1 2023$170,195
-14.6%
9,982,064
+0.0%
0.02%
-21.9%
Q4 2022$199,358
-99.9%
9,977,911
+4.5%
0.03%
-5.9%
Q3 2022$205,670,000
-35.7%
9,548,247
-41.1%
0.03%
-15.0%
Q2 2022$319,910,000
-14.2%
16,222,623
+2.3%
0.04%
+5.3%
Q1 2022$372,669,000
-10.7%
15,858,261
+3.5%
0.04%0.0%
Q4 2021$417,350,000
+2.8%
15,321,204
+3.9%
0.04%0.0%
Q3 2021$405,951,000
-0.8%
14,740,432
+2.6%
0.04%0.0%
Q2 2021$409,047,000
+6.3%
14,372,685
+27.2%
0.04%
-2.6%
Q1 2021$384,965,000
+19.8%
11,302,545
+17.1%
0.04%
+18.2%
Q4 2020$321,325,000
+5.2%
9,652,304
+1.6%
0.03%
-5.7%
Q3 2020$305,306,000
+15.9%
9,499,250
-0.7%
0.04%
+6.1%
Q2 2020$263,483,000
+135.6%
9,567,299
+37.1%
0.03%
+83.3%
Q1 2020$111,832,000
-28.3%
6,976,409
+6.8%
0.02%
-10.0%
Q4 2019$155,955,000
+30.1%
6,530,775
-3.9%
0.02%
+17.6%
Q3 2019$119,901,000
-33.6%
6,797,128
-3.7%
0.02%
-32.0%
Q2 2019$180,684,000
-21.2%
7,057,967
-10.5%
0.02%
-26.5%
Q1 2019$229,231,000
+101.4%
7,885,495
-9.1%
0.03%
+78.9%
Q4 2018$113,834,000
-46.4%
8,676,398
-17.4%
0.02%
-38.7%
Q3 2018$212,315,000
-28.2%
10,500,244
-16.0%
0.03%
-31.1%
Q2 2018$295,613,000
+4.3%
12,499,490
-0.6%
0.04%0.0%
Q1 2018$283,308,000
-30.3%
12,580,281
-3.4%
0.04%
-31.8%
Q4 2017$406,232,000
+1.2%
13,028,622
+1.3%
0.07%
-4.3%
Q3 2017$401,351,000
+127.2%
12,859,684
+24.9%
0.07%
+115.6%
Q2 2017$176,654,000
-6.7%
10,294,551
-4.8%
0.03%
-8.6%
Q1 2017$189,252,000
+36.1%
10,808,219
+2.9%
0.04%
+25.0%
Q4 2016$139,007,000
-4.6%
10,506,925
+4.7%
0.03%
-3.4%
Q3 2016$145,750,000
+47.7%
10,037,872
+0.3%
0.03%
+38.1%
Q2 2016$98,704,000
-19.2%
10,010,522
+3.8%
0.02%
-19.2%
Q1 2016$122,203,000
-27.4%
9,645,081
+4.0%
0.03%
-25.7%
Q4 2015$168,362,000
+0.3%
9,276,146
+2.6%
0.04%
-5.4%
Q3 2015$167,899,000
-20.5%
9,041,389
+4.5%
0.04%
-14.0%
Q2 2015$211,322,000
+21.4%
8,653,627
+3.4%
0.04%
+19.4%
Q1 2015$174,120,000
+2516.4%
8,371,147
+1845.9%
0.04%
+3500.0%
Q4 2014$6,655,000
+27.2%
430,187
+7.3%
0.00%0.0%
Q3 2014$5,233,000
+292.6%
401,000
+472.6%
0.00%
Q1 2014$1,333,00070,0280.00%
Other shareholders
INSMED INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders